High-performance liquid chromatographic method with UV photodiode-array, fluorescence and mass spectrometric detection for simultaneous determination of galantamine and its phase I metabolites in biological samples
Authors:
- Jana MalákováJMJana Maláková
- Milan NobilisMNMilan Nobilis
- Zbyněk SvobodaZSZbyněk Svoboda
- Miroslav LísaMLMiroslav Lísa
- Michal HolčapekMHMichal Holčapek
- Jaroslav KvětinaJKJaroslav Květina
- Jiří KlimešJKJiří Klimeš
- Vladimír PaličkaVPVladimír Palička
- 1 June 2007
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 853 (1-2) , 265-274
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health (MSM0021620822, MSM0021627502, MZO 00179906)
- Ministerstvo Školství, Mládeže a Tělovýchovy
This publication has 19 references indexed in Scilit:
- Clinical Pharmacokinetics of GalantamineClinical Pharmacokinetics, 2003
- Galantamine — a Novel Cholinergic Drug with a Unique Dual Mode of Action for the Treatment of Patients with Alzheimer's DiseaseCNS Drug Reviews, 2002
- The Metabolism and Excretion of Galantamine in Rats, Dogs, and HumansDrug Metabolism and Disposition, 2002
- Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer’s diseaseBehavioural Brain Research, 2000
- A 5-month, randomized, placebo-controlled trial of galantamine in ADNeurology, 2000
- Potent acetylcholinesterase inhibitors: design, synthesis and structure–activity relationships of alkylene linked bis-galanthamine and galanthamine–galanthaminium saltsBioorganic & Medicinal Chemistry Letters, 2000
- Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's diseaseNeurobiology of Aging, 1991
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- Treatment of respiratory depression with the anticholinesterase drug galanthamine hydrobromideAnaesthesia, 1974